660
Participants
Start Date
June 30, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
CBT-001
CBT-001 eye drop
Vehicle
Formulation without drug
Auckland Eye, Auckland
Eye Institute, Auckland
Sydney Eye Hospital, Sydney
Eyeclinic Albury Wodonga, Albury
The Centre for Eye Research Australia, East Melbourne
Bendigo Eye Clinic, Bendigo
Sunshine Eye Surgeons, St Albans
Southern Eye Specialists, Christchurch
Emerson Clinical Research Institute, LLC, Falls Church
Advanced Research; LLC, Deerfield Beach
Bruce A. Segal, MD, Delray Beach
International Research Center, Tampa
Trinity Research Group, Dothan
The Eye Care Institute, Louisville
Vance Thompson Vision, Sioux Falls
Baylor College of Medicine, Houston
Clinical Trials of Texas, San Antonio
R and R Eye Research, San Antonio
DCT-Shah Research, LLC dba Discovery Clinical Trials, McAllen
Horizon Eye Specialists & LASIK Center, Sun City
Center for Sight, Henderson
Global Research Mangement, Glendale
Shultz Chang Vision, Northridge
Inland Eye Specialists, Hemet
Eye Research Foundation, Newport Beach
Santa Barbara Eye Care, Santa Barbara
West Coast Eye Institute, Bakersfield
North Bay Eye Associates INC, Petaluma
Beijing Tongren Hospital; CMU, Beijing
Advanced Eye Centre PGIMER, Chandigarh
Icare Eye Hospital, Noida
Eye Hospital of Shandong First Medical University, Qingdao
Eye Hospital of Wenzhou Medical University, Wenzhou
The First Affiliated Hospital of NC University, Nanchang
SP Medical College and AG of Hospitals, Bikaner
Xiamen Eye Center of Xiamen University, Xiamen
Netralaya Super Specialty Eye Hospital, Ahmedabad
1st Affiliated Hospital of University of South China, Hengyang
Union Hospital Tongji Medical College, Wuhan
Narayana Nethralaya, Bangalore
Hainan Provincial Eye Hospital, Haikou
West China Hospital of Sichuan University, Chengdu
The Second People's Hospital of Yunnan Province, Kunming
L V Prasad Eye Institute, Bhubaneswar
Lead Sponsor
Cloudbreak Therapeutics, LLC
INDUSTRY